![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 1
Zeitschriftenartikel
Herold, Stephanie 
ORCID: https://orcid.org/0000-0002-8335-8790; Schmidt, Christian; Visco, Carlo; Tilch, Marie-Kristin; Ohler, Anke; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hoenig, Elisabeth; Singer, Susanne; Tucci, Alessandra; Pott, Christiane; Ladetto, Marco; Hess, Georg und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2025):
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment.
In: BMC Cancer, Bd. 25, 1370
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8335-8790; Schmidt, Christian; Visco, Carlo; Tilch, Marie-Kristin; Ohler, Anke; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hoenig, Elisabeth; Singer, Susanne; Tucci, Alessandra; Pott, Christiane; Ladetto, Marco; Hess, Georg und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2025):
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment.
In: BMC Cancer, Bd. 25, 1370
[PDF, 1MB]